Cargando…

Antibody therapy can enhance AngiotensinII-induced myocardial fibrosis

BACKGROUND: Myocardial fibrosis is a pathological process that is characterized by disrupted regulation of extracellular matrix proteins resulting in permanent scarring of the heart tissue and eventual diastolic heart failure. Pro-fibrotic molecules including transforming growth factor-β and connect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosin, Nicole L, Gareau, Alison J, Betsch, Devin, Falkenham, Alec, Sopel, Mryanda J, Lee, Timothy DG, Légaré, Jean-Francois
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021636/ https://www.ncbi.nlm.nih.gov/pubmed/24721281 http://dx.doi.org/10.1186/1755-1536-7-6

Ejemplares similares

Treatment with Activated Protein C (aPC) Is Protective during the Development of Myocardial Fibrosis: An Angiotensin II Infusion Model in Mice
por: Sopel, Mryanda J., et al.
Publicado: (2012)

Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis
por: Wong, Chloe Kok Sum, et al.
Publicado: (2018)

AngiotensinII Preconditioning Promotes Angiogenesis In Vitro via ERKs Phosphorylation
por: Guan, Aili, et al.
Publicado: (2012)

Activation of Yes-Associated Protein/PDZ-Binding Motif Pathway Contributes to Endothelial Dysfunction and Vascular Inflammation in AngiotensinII Hypertension
por: Xu, Qian, et al.
Publicado: (2021)

Recovery free of heart failure after acute coronary syndrome and coronary revascularization
por: Falkenham, Alec, et al.
Publicado: (2017)

Modulation of angiotensin II signaling in the prevention of fibrosis
por: Murphy, Amanda M, et al.
Publicado: (2015)

Abstract QS38: Effect of Compound 21, a Selective Angiotensin II Type 2 Receptor Agonist, in an Abdominal Adhesion Murine Model
por: Boudreau, Colton, et al.
Publicado: (2019)

Recruitment of macrophages from the spleen contributes to myocardial fibrosis and hypertension induced by angiotensin II
por: Wang, Ning-Ping, et al.
Publicado: (2017)

Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice
por: Kakutani, Naoya, et al.
Publicado: (2020)

Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
por: Shu, Jin, et al.
Publicado: (2023)

The Role of the Renin-Angiotensin System in Hepatic Fibrosis
por: Lubel, J.S., et al.
Publicado: (2007)

Matrix metalloproteinase 3 regulates angiotensin II-induced myocardial fibrosis cell viability, migration and apoptosis
por: Shu, Jin, et al.
Publicado: (2021)

Renal Interstitial Fibrosis and Angiotensin Inhibition
por: Koo, Ja Wook
Publicado: (2006)

Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats
por: Pang, Xue-Fen, et al.
Publicado: (2015)

Fibulin-2 is Essential for Angiotensin II-Induced Myocardial Fibrosis Mediated by Transforming Growth Factor (TGF)-β
por: Khan, Shaukat A., et al.
Publicado: (2016)

The sirtuin 6 prevents angiotensin II-mediated myocardial fibrosis and injury by targeting AMPK-ACE2 signaling
por: Zhang, Zhen-Zhou, et al.
Publicado: (2017)

SMOC1 silencing suppresses the angiotensin II-induced myocardial fibrosis of mouse myocardial fibroblasts via affecting the BMP2/Smad pathway
por: Wang, Yize, et al.
Publicado: (2018)

The Prevalence and Effect of Comorbid Cystic Fibrosis and Attention Deficit Hyperactivity Disorders on Hospitalizations: A Retrospective Analysis
por: Spitzer, Nicole, et al.
Publicado: (2018)

Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection
por: Krummey, Scott M., et al.
Publicado: (2022)

Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension
por: Castoldi, Giovanna, et al.
Publicado: (2021)

Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis
por: O’Reilly, Philip J., et al.
Publicado: (2017)

Neuro-Ophthalmologic Manifestations of Novel Coronavirus
por: Betsch, Devin, et al.
Publicado: (2021)

Ghrelin Ameliorates Angiotensin II-Induced Myocardial Fibrosis by Upregulating Peroxisome Proliferator-Activated Receptor Gamma in Young Male Rats
por: Wang, Qian, et al.
Publicado: (2018)

Attenuation of Myocardial Fibrosis with Curcumin Is Mediated by Modulating Expression of Angiotensin II AT1/AT2 Receptors and ACE2 in Rats [Corrigendum]
Publicado: (2020)

Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention
por: Legere, Stephanie A., et al.
Publicado: (2019)

Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis
por: Stawski, Lukasz, et al.
Publicado: (2012)

Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis()
por: Herath, Chandana B., et al.
Publicado: (2007)

Management and Complications of Dexamethasone Intravitreal Implant Migration Into the Anterior Chamber
por: Betsch, Devin M., et al.
Publicado: (2022)

Endothelial NADPH oxidase 4 protects against angiotensin II‐induced cardiac fibrosis and inflammation
por: Wang, Minshu, et al.
Publicado: (2021)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk
por: Dézsi, Csaba András, et al.
Publicado: (2016)

Social and ecological conditions of cranberry production and climate change attitudes in New England
por: Gareau, Brian J., et al.
Publicado: (2018)

Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis
por: Wang, Jiaolong, et al.
Publicado: (2015)

Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis
por: Zhu, Qianqian, et al.
Publicado: (2016)

Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension
por: Shim, Kwang Yong, et al.
Publicado: (2018)

Angiotensin II Receptor Blocker Attenuates Intrarenal Renin-Angiotensin-System and Podocyte Injury in Rats with Myocardial Infarction
por: Wen, Zhu-zhi, et al.
Publicado: (2013)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction
por: Chen, Chih-Wei, et al.
Publicado: (2023)

The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
por: Kotak, Sohny, et al.
Publicado: (2023)

Prolylcarboxypeptidase Alleviates Hypertensive Cardiac Remodeling by Regulating Myocardial Tissue Angiotensin II
por: Nguyen, Binh Y., et al.
Publicado: (2023)

Roles of Biomarkers in Myocardial Fibrosis
por: Ding, Yuejia, et al.
Publicado: (2020)

Drugs for treating myocardial fibrosis
por: Ren, Zhanhong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_umd1uskbbjv96a11acdknrt8t7